Literature DB >> 17101559

Toll-like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions.

J Hernesniemi1, T Lehtimäki, R Rontu, M S Islam, C Eklund, J Mikkelsson, E Ilveskoski, O Kajander, S Goebeler, L E Viiri, M Hurme, P J Karhunen.   

Abstract

OBJECTIVE: Atherosclerosis is considered to be a chronic inflammatory disease. Toll-like receptor 4 (TLR-4), a key mediator in activating inflammatory cascade, has an A-to-G functional polymorphism that changes aspartic acid to glycine at position 299. TLR-4 is activated by, for example, lipopolysaccharides. The purpose of this study was to investigate the role of a common Asp299Gly polymorphism of the TLR-4 gene in atherosclerosis.
MATERIAL AND METHODS: The study comprised autopsy material from 657 men (the Helsinki Sudden Death Study; mean age 53, range 33-70 years).
RESULTS: Fewer G-allele carriers had 3-vessel coronary artery disease compared with AA homozygotes (OR 0.32; 95 % CI, 0.12-0.88, p = 0.027), and they also had a lower mean value for maximal coronary stenosis (p = 0.019). TLR-4 polymorphism was not significantly associated with the occurrence of acute or old myocardial infarction (MI).
CONCLUSIONS: The G allele of the TLR-4 gene, which is associated with a lower inflammation response, was associated with a lower risk of coronary stenosis but not with the occurrence of MI and hence is not a major factor in the development of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101559     DOI: 10.1080/00365510600933011

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells.

Authors:  Junfei Jin; Devadoss J Samuvel; Xiaoming Zhang; Yanchun Li; Zhongyang Lu; Maria F Lopes-Virella; Yan Huang
Journal:  Mol Immunol       Date:  2011-10-26       Impact factor: 4.407

2.  Quantitative assessment of TLR4 gene polymorphisms and T2DM risk: A meta-analysis.

Authors:  Jinzhuo Fan; Renxian Liang
Journal:  Mol Genet Genomic Med       Date:  2020-08-21       Impact factor: 2.183

3.  Genetic variation and atherosclerosis.

Authors:  Erik Biros; Mirko Karan; Jonathan Golledge
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

4.  Rosiglitazone alleviates lipopolysaccharide-induced inflammation in RAW264.7 cells via inhibition of NF-κB and in a PPARγ-dependent manner.

Authors:  Jing-Ping Zhou; Xiao-Ning Yang; Yang Song; Fei Zhou; Jing-Jing Liu; Yi-Qun Hu; Li-Gang Chen
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

5.  Association between Toll-like receptor 4 Asp299Gly polymorphism and coronary heart disease susceptibility.

Authors:  B W Wu; J Zhu; H M Shi; B Jin; Z C Wen
Journal:  Braz J Med Biol Res       Date:  2017-08-07       Impact factor: 2.590

6.  Association of TLR and TREM-1 gene polymorphisms with atherosclerosis severity in a Russian population.

Authors:  Anton G Kutikhin; Anastasia V Ponasenko; Maria V Khutornaya; Arseniy E Yuzhalin; Irina I Zhidkova; Ramil R Salakhov; Alexey S Golovkin; Olga L Barbarash; Leonid S Barbarash
Journal:  Meta Gene       Date:  2016-04-19

7.  TLR4 Asp299Gly (rs4986790) polymorphism and coronary artery disease: a meta-analysis.

Authors:  Rui Chen; Ning Gu; Ying Gao; Wei Cen
Journal:  PeerJ       Date:  2015-11-26       Impact factor: 2.984

8.  Genetic association of Toll-like receptor 4 gene and coronary artery disease in a Chinese Han population.

Authors:  Liting Zhou; Dongchun Zheng; Shuyue Wang; Jian Zhu; Yiyang Jia; Di Sun; Jin Xu; Qi Wang; Huaiji Chen; Feng Xu; Bo Li; Lin Ye
Journal:  Springerplus       Date:  2016-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.